The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Advantages and challenges of mass spectrometry assays for steroid hormones
Abstract
Although steroid hormones have been measured, primarily in urine, by gas chromatography-mass spectrometry (GC-MS) assays for many years, in the past decade both clinical and research laboratories have dramatically increased usage of liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays for measuring circulating levels of steroid hormones. Because of their high validity and throughput, mass spectrometry (MS) assays have replaced conventional radioimmunoassays (RIAs) and direct immunoassays for steroid hormones in larger reference laboratories, and they are touted to become the "gold standard" for steroid hormone quantitation. These advances in MS assays present several major challenges, which include the affordability of smaller laboratories to purchase MS instruments and pay for related operating costs; improving assay sensitivity, especially for measuring low estradiol levels in postmenopausal women and women treated with aromatase inhibitors; developing assays for quantitating profiles of steroid hormone metabolites in serum and tissues; standardizing steroid MS assays; and obtaining reliable reference intervals. The present review discusses the advantages of MS assays over conventional RIAs and direct immunoassays in steroid hormone measurements, and points out some of the important challenges facing the rapid increase in usage of MS assays.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liquid chromatography–mass spectrometry is well accepted as the preferred technique for the analysis of testosterone [90, 91].”
From Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement (2021) · cites this paper as [90]
Citations
Cites
Ion Suppression in Mass Spectrometry
Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,598
Electrospray ionization–principles and practice
Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1990) · Mass Spectrometry Reviews · doi:10.1002/mas.1280090103 · Cited by 1,569
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Solid-Phase Radioimmunoassay of Estradiol-17β
Abraham, G. E. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-6-866 · Cited by 840
Taieb, J., Mathian, B., Millot, F., Patricot, M. C., Mathieu, E., Queyrel, N., Lacroix, I., Somma-Delpéro, C., & Boudou, P. (2003) · Clinical Chemistry · doi:10.1373/49.8.1381 · Cited by 638
Wang, C., Catlin, D. H., Demers, L. M., Starcevic, B., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031287 · Cited by 580
Xu, X., Roman, J. M., Issaq, H. J., Keefer, L. K., Veenstra, T. D., & Ziegler, R. G. (2007) · Analytical Chemistry · doi:10.1021/ac070494j · Cited by 260
Sikaris, K., McLachlan, R. I., Kazlauskas, R., de Kretser, D., Holden, C. A., & Handelsman, D. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0962 · Cited by 259
Shackleton, C. H. L., & Whitney, J. O. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90451-9 · Cited by 252
Xu, X., Veenstra, T. D., Fox, S. D., Roman, J. M., Issaq, H. J., Falk, R., Saavedra, J. E., Keefer, L. K., & Ziegler, R. G. (2005) · Analytical Chemistry · doi:10.1021/ac050697c · Cited by 227
Research works printed but not linked: 1
- Singh, 2008, Improving patient care with tandem mass spectrometry, Clin. Lab. News, 34, 12
Cited by
Sorted by citations
Challenges to the measurement of estradiol: an Endocrine Society Position Statement
Rosner, W., Hankinson, S. E., Sluss, P. M., Vesper, H. W., & Wierman, M. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3780 · Cited by 408
Munar, A., Frazee, C., & Garg, U. C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3182-8_29 · Cited by 378
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
Rothman, M. S., Carlson, N. E., Xu, M., Wang, C., Swerdloff, R., Lee, P., Goh, V. H. H., Ridgway, E. C., & Wierman, M. E. (2011) · Steroids · doi:10.1016/j.steroids.2010.10.010 · Cited by 248
Testosterone, cortisol, and human competition
Casto, K. V., & Edwards, D. A. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.04.004 · Cited by 228
Metadata
- Authors
- Stanczyk, F. Z., & Clarke, N. J.
- Affiliations
- University of Southern California (US)
- Quest Diagnostics (United States) (US)
- Corresponding author
- Stanczyk, Frank Z.
- ORCID
- Stanczyk, Frank Z.
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 121
- Issue
- 3-5
- Pages
- 491-495
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W1985139791
- Cited by
- 265
- References
- 24
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 5 · 2023: 17 · 2022: 22 · 2021: 15 · 2020: 17 · 2019: 16 · 2018: 17 · 2017: 15 · 2016: 23 · 2015: 19 · 2014: 20 · 2013: 21 · 2012: 11
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Steroid Biochemistry and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- steroid hormones, mass spectrometry assay, LC-MS/MS, gas chromatography-mass spectrometry, radioimmunoassay comparison, estradiol measurement, aromatase inhibitors, postmenopausal women, steroid hormone metabolites, assay standardization, reference values, assay sensitivity
- MeSH terms
- Female, Hormones, Humans, Gas Chromatography-Mass Spectrometry, Radioimmunoassay, Steroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
